NAFDAC Bans Mars Cures PVT Restricted for Manufacturing Faux Medicines
An Indian firm has been banned in Nigeria by the Nationwide Company for Meals and Drug Administration and Management (NAFDAC).
In accordance with the company, Mars Cures PVT Restricted, India was banned for manufacturing faux drugs for a pharmaceutical firm in Nigeria.
The Company made this recognized in an announcement signed by its Director-Common, Prof. Mojisola Adeyeye on Tuesday in Abuja.
Adeyeye mentioned all merchandise manufactured by Mars Cures PVT, 635, GIDC Property Waghodia Vadodara, Gujurat, India, resulting from unprofessional practices have been banned from importation into Nigeria with quick impact.
In accordance with her, the company has zero tolerance for substandard merchandise.
The Director-Common additionally mentioned that the company has additionally blacklisted Ciprofloxacin tablets BP 500mg with NAFDAC Reg. No. C4-0498 which was manufactured for Pinnacle Well being Pharmaceutical, Surulere, Lagos.
“In violation of NAFDAC extant legal guidelines and rules, the corporate illegally manufactured completely different formulations of Ciprofloxacin tablets as an alternative of the authorized formulation for export to Nigeria.
“The variation within the formulation of the Ciprofloxacin 500mg tablets, which can impression on the product high quality and shelf life, was not authorized by the company earlier than these adjustments had been made.
“This constitutes a violation of the NAFDAC Act.
“The corporate has displayed an apparent disregard for compliance with international requirements essential to guarantee the manufacturing of high quality merchandise.”